Brief: WntResearch gets patent application approval from Canadian patent office
Sept 6 (Reuters) - Wntresearch AB WNT.ST :
* Says has received an approval from the Canadian patent office, Canadian Intellectual
Property Office (CIPO), on its patent application for its drug candidate Box-5 and similar
peptides for the treatment of malignant melanoma and gastric cancer
Source text: http://bit.ly/2c4aysL
Further company coverage: WNT.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Opsy Holding AB
See all newsBrief: Wntresearch Says Co To Initially Receive About Sek 31.4 Million Before Issue Costs
Brief: WNTresearch Q4 Net Loss Narrows To SEK 6.1 Million
Brief: Wntresearch Intends To Carry Out Fully Secured Rights Issue Of Units Of SEK 55 Million
Brief: Wntresearch Updates On Neofox Study With Regards To COVID-19
Brief: WntResearch Appoints New CFO